Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M449Revenue (TTM) $M48.2Net Margin (%)-158.6Altman Z-Score-4.8
Enterprise Value $M441EPS (TTM) $-1.2Operating Margin %-151.6Piotroski F-Score2
P/E(ttm)--Beneish M-Score-1.6Pre-tax Margin (%)-158.6Higher ROA y-yN
Price/Book57.010-y EBITDA Growth Rate %--Quick Ratio7.5Cash flow > EarningsY
Price/Sales9.35-y EBITDA Growth Rate %-8.0Current Ratio7.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-42.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-208.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M63.5ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with XNPT

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
XNPTMario Gabelli 2016-06-30 Buy $4.04 - $7.09
($5.63)
$ 7.0726%New holding32,500
XNPTCharles Brandes 2015-06-30 Sold Out $5.61 - $7.6
($6.55)
$ 7.078%Sold Out0
XNPTCharles Brandes 2014-12-31 Buy $5.39 - $8.9
($7.36)
$ 7.07-4%New holding19,700
XNPTGeorge Soros 2011-12-31 Sold Out -0.0016%$3.57 - $6.34
($4.97)
$ 7.0742%Sold Out0
XNPTGeorge Soros 2011-09-30 Reduce$5.95 - $7.72
($7)
$ 7.071%Reduce -38.17%16,200
XNPTGeorge Soros 2011-06-30 Buy $6.05 - $9.31
($7.57)
$ 7.07-7%New holding26,200
XNPTBill Gates 2009-06-30 Sold Out -0.03%$13.58 - $21.66
($18.31)
$ 7.07-61%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

XNPT is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


XNPT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Flynn James E 2016-02-19Buy20,973$3.9977.19view
Flynn James E 2016-02-12Buy4,883,761$3.8782.69view
Flynn James E 2016-01-20Buy346,417$4.0972.86view
Freund John GordonDirector 2015-11-11Sell909$6.685.84view
Barrett Ronald WCEO 2015-09-01Sell12,500$71view
Barrett Ronald WCEO 2015-07-15Sell25,000$7.1-0.42view
WIERENGA WENDALLDirector 2015-05-11Buy5,000$5.6325.58view
RIEFLIN WILLIAM JLDirector 2014-12-10Sell11,010$8.49-16.73view
Barrett Ronald WCEO 2014-12-08Sell7,015$8.36-15.43view
BATES GREGORY TSVP, Regulatory Affairs & QA 2014-12-08Sell14,166$8.35-15.33view

Quarterly/Annual Reports about XNPT:

News about XNPT:

Articles On GuruFocus.com
XenoPort Inc. Reports Operating Results (10-Q) Nov 09 2010 
XenoPort Inc. Reports Operating Results (10-Q) Aug 06 2010 
XenoPort Inc. Reports Operating Results (10-Q) May 10 2010 
Xenoport - A Shaking Ham Hock Feb 07 2010 
XenoPort Inc. Reports Operating Results (10-Q) Aug 06 2009 
Weekly Top Insider Buys: Alcoa Inc., ABM Industries Inc., Valhi Inc., XenoPort Inc., and Methode Ele Jul 11 2009 
XenoPort Inc. Reports Operating Results (10-Q) May 07 2009 
Weekly Top Insider Buys: Sovereign Bancorp Inc., Jefferies Group Inc., XenoPort Inc., Sandridge Ener May 24 2008 

More From Other Websites
XENOPORT INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of... Jul 05 2016
Arbor Pharmaceuticals Completes Successful Tender Offer for Shares of XenoPort Jul 05 2016
Arbor Pharmaceuticals Completes Successful Tender Offer for Shares of XenoPort Jul 05 2016
What Brexit Vote Could Mean for U.S. 2016 Election Jun 22 2016
Lifshitz & Miller Law Firm Announces Investigation of Exterran Corporation, inContact, Inc.,... Jun 20 2016
Arbor Pharmaceuticals and XenoPort Announce the Expiration of the HSR Act Waiting Period Jun 16 2016
Arbor Pharmaceuticals and XenoPort Announce the Expiration of the HSR Act Waiting Period Jun 16 2016
Surging Earnings Estimates Signal Good News for Xenoport (XNPT) Jun 06 2016
SHAREHOLDER ALERT: Law Offices of Marc S. Henzel Announces Investigation into the proposed sales and... Jun 02 2016
SHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of... May 27 2016
XENOPORT SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Xenoport, Inc.... May 26 2016
The Zacks Analyst Blog Highlights: XenoPort, Biodel and AbbVie May 26 2016
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning Whether the Sale of... May 25 2016
Biotech Stock Roundup: XenoPort Soars on Acquisition Deal, AbbVie Crohn's Disease Drug Fares Well May 25 2016
SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of XenoPort, Inc.... May 24 2016
Xenoport Surges on Takeover Bid and Outperforms the Market May 24 2016
ETF’s with exposure to XenoPort, Inc. : May 24, 2016 May 24 2016
Arbor Pharmaceuticals to buy XenoPort for $467 million May 24 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)